The Brewers Association is monitoring the potential impact of GLP-1 medications on demand for craft beer, but current information is not sufficient to confirm that they are causing sales to decline. This article reviews the Association’s recommendations on social media management, margin analysis, and low-cost bar and food offerings, and examines how potential changes in demand may affect production, inventory, and procurement. It helps brewers and channel businesses identify operational risks, verify sales data, and explore more resilient ways to adjust their operations.